Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Callisto acquires rights to novel cancer technology platform

March 1, 2004

Promising preclinical results with Vertex's Aurora kinase inhibitor VX-680

March 1, 2004

Gabapentin found effective against tamoxifen-related hot flashes in breast cancer

March 1, 2004

Orphan drug designation for CG-53135

Feb. 27, 2004

Mitsui Chemicals claims telomerase inhibitors for cancer and other uses

Feb. 27, 2004

Neoprobe to meet FDA concerning RIGScan CR49 BLA

Feb. 27, 2004

Attenuon and Kirin Brewery enter antibody collaboration for cancer

Feb. 27, 2004

Good efficacy and safety profile found for R-115777 in MDS

Feb. 26, 2004

SuperGen acquires European marketing authorizations for Nipent

Feb. 26, 2004

New tubulin polymerization inhibitors covered by Zentaris patent

Feb. 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.